News

ThermoDox is currently being assessed under a Special Protocol Assessment with the US Food and Drug Administration in a 600 patient pivotal Phase III trial, the HEAT study,

MetaVision was chosen to standardize and improve data collection, to track performance measures, and to report on anesthesia quality and compliance indicators. The MetaVision Anesthesia Information Management System

SuperGen has posted a net income of $6.75m for the fourth quarter of 2010, compared to $2.34m for the same period in 2009.SuperGen’ income from operations was $6.49m,

In this collaboration, tumor specimens from subjects treated with IRX-2 and control subjects will be analyzed by the collaborating company using gene analysis technology in order to characterize

Previously those products were marketed by ‘Kyowa Kyowa Hakko Bio, reported thehindubusinessline.com. Daiichi Sankyo and Kyowa Hakko Bio had agreed to transfer the marketing rights of the products

Earlier in February 2010, Meda has got exclusive license for marketing, selling and distributing Xerese in the US, Canada and Mexico for the treatment of cold sores (herpes

The approval is based on the satisfactory results obtained from a 9-week, multicenter, double-blind, randomized, placebo-controlled study of INTUNIV in combination with a stimulant in children and adolescents

Under the pact, Novavax will provide VLP technology transfer and manufacturing support for LGLS’s new vaccine production facility. As per the agreement, LGLS will be manufacture, develop and

Novavax has got $97m for first three years with an option to extend for additional two years for a total contract value of $179.1m. However, HHS has awarded